the aid library

LIST OPTIONS

Filter

27968

Direction:

Download (57)

View PDF (55)

Assessing the nature of asthma in African epidemiological studies: a scoping review protocol

Ndlovu, V.; Chimbari, M.J.; Sibanda, E. (2020) CC2

Asthma is one of the most common chronic respiratory conditions in the world and is increasing in prevalence, particularly in Africa and other low-income countries. The disproportionately high numbers of premature deaths and severe or uncontrolled cases in many African countries are indicative of th... more

Download (123)

View PDF (60)

Assessing the nature of asthma in African epidemiological studies: a scoping review protocol 2020

Ndlovu, V.; Chimbari, M.J.; Sibanda, E. (2020) CC2

Download (75)

View PDF (68)

Asbestos-related cancers: the‘Hidden Killer’remains a global threat

van Zandwijk, N.; Reid, G.; Frank, A. EXPERT REVIEW OF ANTICANCER THERAPY2020, VOL. 20, NO. 4, 271–278 (2020) CC2

Asbestos, the most frequent cause of occupational cancer, continues to be consumed ona massive scale, with millions of people exposed on a daily basis. This review explains why we havefailed in curtailing the silent epidemic of asbestos-related disease and why the numbers of asbestosvictims are like... more

Download (134)

View PDF (85)

Asbestosis - Medscape

Jackson, C. D.; Mosenifar, Z.; Medscape (2020) CC2

Asbestosis is a process of diffuse interstitial fibrosis of the lung due to exposure to asbestos dust. Asbestos is the name given to a group of naturally occurring minerals that are resistant to heat and corrosion; these include mineral fibers such as chrysotile, amosite, and crocidolite, among oth... more

Download (44)

View PDF (43)

Fig. 1: GINA treatment recommendations for patients aged ≤5 years, 6–11 years and ≥12 years

npj Primary Care Respiratory Medicine (2020) CC2

Adults and adolescents 12+ years. Asthma medication options: Adjust treatment up and down for individual patient needs

Download (56)

View PDF (57)

Outcome of illustrated information leaflet on correct usage of asthma-metered dose inhaler

Wrench, W.; van Dyk, L.; Sirinivas, S.; Dowse, R. African Journal of Primary Health Care & Family Medicine (2019) CC2

Research globally has shown that metered dose inhaler (MDI) technique is poor, with patient education and regular demonstration critical in maintaining correct use of inhalers. Patient information containing pictorial aids improves understanding of medicine usage; however, manufacturer leaflets illu... more

Download (70)

View PDF (73)

Under- and over-diagnosis of COPD: a global perspective

Ho T., Cusack R.P., Chaudhary N. et al. Breathe, part of the European Respiratory Society (ERS) (2019) CC2

The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet... more

Download (102)

View PDF (65)

Urbanisation and asthma in low-income and middleincome countries: a systematic review of the urbanrural differences in asthma prevalence

Rodriguez, A.; Brickley, E.; Rodrigues, L.; et al. (2019) CC2

Urbanisation has been associated with temporal and geographical differences in asthma prevalence in low-income and middle-income countries (lMics). however, little is known of the mechanisms by which urbanisation and asthma are associated, perhaps explained by the methodological approaches used to a... more

Download (72)

View PDF (54)

Physical Inactivity: The Major Risk Factor for Non-Communicable Diseases

Haileamlak, A. Ethiopian Journal of Health Sciences (2019) CC

The document discusses physical inactivity as a major risk factor for non-communicable diseases (NCDs), which contribute to two-thirds of global deaths, primarily in low- and middle-income countries. It emphasizes the global prevalence of physical inactivity and its health risks, such as increased m... more

Download (131)

View PDF (85)

Chronic obstructive pulmonary disease in over 16s: non-pharmacological management and use of inhaled therapies

National Institute for Communicable Disease (NICE) National Institute for Health and Care Excellence (NICE) (2019) CC2

The document provides a summary of recommendations for the non-pharmacological management of chronic obstructive pulmonary disease (COPD) and the use of inhaled therapies in individuals over 16, emphasizing confirmed diagnosis, treatment options, and regular review of treatment effectiveness and inh... more

Download (76)

View PDF (74)

Silica-associated lung disease: An old-world exposure in modern industries

Barnes, H.; Goh, N. S. L.; Leong, T. L.; Hoy, R. Official Journal of the Asian Pacific Society of Respirology (2019) CC2

Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,... more

Download (62)

View PDF (66)

Management of chronic obstructive pulmonary disease—A position statement of the South African Thoracic Society: 2019 update

Abdool-Gaffar, M. S.; Calligaro, G.; Wong, M.L. et al. Journal of Thoracic Disease (2019) CC2

The document outlines the 2019 update to the South African guideline for managing chronic obstructive pulmonary disease (COPD). It emphasizes the importance of early diagnosis, prevention through smoking cessation, use of bronchodilators as primary pharmacotherapy, and a comprehensive approach to pa... more

Download (56)

View PDF (64)

COPD (acute exacerbation): antimicrobial prescribing

National Institute for Communicable Disease (NICE) National Institute for Communicable Disease (NICE) (2019) CC2

The NICE guideline NG114 provides recommendations on antimicrobial therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD), aiming to optimize antibiotic use and minimize the development of antibiotic resistance.

Download (56)

View PDF (78)

The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature

Rehman, A.; Ahmad Hassali, M.A.; Muhammad, S.A. et al. (2019) CC2

Lack of information about economic burden of COPD is a major cause of lack of attention to this chronic condition from governments and policymakers.

Download (65)

View PDF (53)

Chronic Obstructive Pulmonary Disease (COPD) - Patient Education; Information

Lareau S.C., Fahy B. et al American Thoracic Society (2019) CC2

The document by the American Thoracic Society provides an overview of Chronic Obstructive Pulmonary Disease (COPD), explaining its causes, such as smoking and environmental factors, symptoms like breathlessness and chronic cough, and diagnostic methods including spirometry. It discusses treatment st... more

Download (53)

View PDF (47)

Explainer: What is silicosis?

The Royal Australian College of General Practitioners (2019) CC2

Silicosis is a group of occupational lung diseases caused by breathing in silica dust. It has been described since ancient times, when miners and stonecutters were exposed to dust containing this crystalline mineral.

Download (48)

View PDF (54)

What You Can Do About a Lung Disease Called COPD

Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2019) CC2

The "GOLD Patient Guide 2019" explains Chronic Obstructive Pulmonary Disease (COPD), its causes, symptoms, and stages. It provides practical advice for managing COPD, including the importance of quitting smoking, following medical treatment plans, exercising, maintaining a healthy diet, and creating... more

Download (58)

View PDF (59)

A systematic map and in-depth review of European telehealth interventions efficacy for chronic obstructive pulmonary disease

Gaveikaite, V.; Grunstrom, C.; Winter, S.; et al. Respiratory Medicine (2019) CC2

The article investigates the effectiveness and challenges of remote monitoring systems for chronic respiratory diseases, focusing on COPD and asthma. It reviews various technologies and their potential to improve patient outcomes through better symptom tracking, medication adherence, and early detec... more

Download (67)

View PDF (67)

Chronic obstructive pulmonary disease in over 16s: diagnosis and management

National Institute for Health and Care Excellence - NICE (2018) CC2

This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, impr... more

Download (54)

View PDF (38)

Tackling injustices of occupational lung disease acquired in South African mines: recent developments and ongoing challenges

Kistnasamy, B.; Yassi, A.; Yu, J. et al. BMC Part of Springer Nature (2018) CC2

South Africa’s mineral resources have produced, and continue to produce, enormous economic wealth; yet decades of colonialism, apartheid, capital flight, and challenges in the neoliberal post-apartheid era have resulted in high rates of occupational lung disease and low rates of compensation for e... more